Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

Priest Dies of Ebola; UN Debates Treatment Ethics

August 12, 2014 8:21 am | by Maria Cheng and Ciaran Giles - Associated Press - Associated Press | News | Comments

A Spanish missionary priest being treated for Ebola died Tuesday in a Madrid hospital amid a worldwide debate over who should get experimental Ebola treatments. After holding a teleconference with medical experts around the world, the WHO declared it is ethical to use unproven Ebola drugs and vaccines in the current outbreak.

TOPICS:

Sanford getting $7.1M grant for cancer research

August 12, 2014 8:21 am | by The Associated Press | News | Comments

The National Cancer Institute of the National Institutes of Health is giving Dakotas-based Sanford Health more than $7.1 million over five years for cancer research. The money will be used to recruit participants for clinical trials, quality-of-life studies and research on the delivery of cancer...

UN: It's ethical to try untested Ebola medicines

August 12, 2014 7:17 am | by Ciaran Giles - Associated Press - Associated Press | News | Comments

The World Health Organization said it's ethical to use unproven Ebola drugs and vaccines in the outbreak in West Africa provided the right conditions are met. The U.N. agency issued the statement Tuesday after holding a teleconference with experts Monday to discuss the issue. In the biggest-ever...

Advertisement

Asbestos pushed in Asia as product for the poor

August 12, 2014 3:20 am | by Katy Daigle - AP Environment Writer - Associated Press | News | Comments

The executives mingled over tea and sugar cookies, and the chatter was upbeat. Their industry, they said at the conference in the Indian capital, saves lives and brings roofs, walls and pipes to some of the world's poorest people. The industry's wonder product, though, is one whose very name...

Ebola death toll in West Africa passes 1,000

August 11, 2014 10:21 pm | by The Associated Press | News | Comments

The World Health Organization says the death toll in the Ebola outbreak in West Africa has passed 1,000. The U.N. health agency said in a news release Monday that 1,013 people have died in the outbreak, which has hit Guinea, Liberia, Sierra Leone and possibly Nigeria. Authorities have recorded...

Liberian doctors to get experimental Ebola drug

August 11, 2014 8:21 pm | by By Jonathan Paye-layleh - Associated Press - Associated Press | News | Comments

The Liberian government says it will receive doses of an experimental Ebola drug to treat doctors in the West African country. The U.S. government confirmed that it had put Liberian officials in touch with the maker of ZMapp, and referred additional questions to Mapp Biopharmaceutical Inc. It...

Firm halting sales of dietary supplement Anatabloc

August 11, 2014 6:20 pm | by Michael Felberbaum - AP Business Writer - Associated Press | News | Comments

The dietary supplement maker at the center of a federal trial of former Virginia Gov. Bob McDonnell and his wife says it's halting sales of its product called Anatabloc. Rock Creek Pharmaceuticals Inc. said Monday it is voluntarily stopping sales while it sorts out issues with the Food and Drug...

FDA approves first DNA-based test for colon cancer

August 11, 2014 5:21 pm | by Matthew Perrone - AP Health Writer - Associated Press | News | Comments

The Food and Drug Administration has approved the first screening test for colon cancer that uses patient DNA to help spot potentially deadly tumors and growths. The Cologuard test from Exact Sciences detects irregular mutations in a patient's stool sample that can be an early warning sign of...

Advertisement

Ebola: Questions, answers about an unproven drug

August 11, 2014 5:20 pm | by Lauran Neergaard - AP Medical Writer - Associated Press | News | Comments

A Spanish missionary priest is the third Westerner with Ebola to be treated with an experimental drug that's never been tested in people and is said to be in very limited supply. Spanish authorities' disclosure on Monday raised further ethical questions about why no Africans have received the...

Idiopathic Pulmonary Fibrosis: Hope, At Last

August 11, 2014 2:26 pm | by Cynthia Fox | Articles | Comments

There have been stunning “firsts” in research on idiopathic pulmonary fibrosis (IPF), a mysterious disease that stiffens and stills the lungs, killing half its victims in three years. In May, results of Phase 3 clinical trials on the first two effective drugs for IPF were published in the New England Journal of Medicine (NEJM). And in June, the first paper explaining IPF was published in Science Translational Medicine.

TOPICS:

Panel for Cancer Pathway Analysis

August 11, 2014 2:18 pm | Product Releases | Comments

The NanoString nCounter PanCancer Pathways Panel is a highly-multiplexed, digital gene expression assay that offers a unique way for translational researchers to investigate cancer biology across all major cancer pathways.

Editing HPV's Genes to Kill Cervical Cancer Cells

August 11, 2014 2:13 pm | News | Comments

Researchers have hijacked a defense system normally used by bacteria to fend off viral infections and redirected it against the human papillomavirus (HPV), the virus that causes cervical, head and neck, and other cancers.Using the genome editing tool known as CRISPR, the Duke University researchers were able to selectively destroy two viral genes responsible for the growth and survival of cervical carcinoma cells.

TOPICS:

Scientists Unlock Key to Blood Vessel Formation

August 11, 2014 2:09 pm | News | Comments

Scientists from the University of Leeds have discovered a gene that plays a vital role in blood vessel formation, research which adds to our knowledge of how early life develops. The discovery could also lead to greater understanding of how to treat cardiovascular diseases and cancer.

TOPICS:

Newly Discovered Heart Molecule Could Lead to Effective Treatment for Heart Failure

August 11, 2014 2:04 pm | News | Comments

Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure. The newly discovered molecule provides the heart with a tool to block a protein that orchestrates genetic disruptions when the heart is subjected to stress, such as high blood pressure.

TOPICS:

Like Cling Wrap, New Biomaterial Can Coat Burn Wounds and Block Infection

August 11, 2014 2:01 pm | News | Comments

Wrapping wound dressings around fingers and toes can be tricky, but for burn victims, guarding them against infection is critical. Today, scientists are reporting the development of novel, ultrathin coatings called nanosheets that can cling to the body’s most difficult-to-protect contours and keep bacteria at bay.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading